Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 480
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,461 Results (Page 47 of 124)
- Relevance
  Sort by

Specialty Pharmaceuticals Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
August 2022
110 Pages
Global

From

€4690EUR$4,750USD£3,917GBP

Occupational Medicines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
August 2022
117 Pages
Global

From

€4690EUR$4,750USD£3,917GBP

Rheumatoid Arthritis Medication Manufacturing in the US - Industry Market Research Report

 Report
October 2021
41 Pages
United States

From

€1007EUR$1,020USD£841GBP

Colorectal Cancer: Global Drug Forecast and Market Analysis to 2028

 Report
April 2020
153 Pages
Global

From

€10857EUR$10,995USD£9,066GBP

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups

 Report
August 2022
59 Pages
Germany

€9916EUR$10,393USD£8,000GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups

 Report
August 2022
58 Pages
Asia Pacific

€9916EUR$10,393USD£8,000GBP

Dendritic Cell Cancer Vaccine Market Size, Share & Trends Analysis Report By Products (CreaVax, Sipuleucel-T), By End-use (Pediatrics, Adults), By Region, And Segment Forecasts, 2023 - 2030

 Report
November 2022
200 Pages
Global

From

€5875EUR$5,950USD£4,906GBP

Ulcerative Colitis (UC) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031

 Drug Pipelines
March 2023
125 Pages
Global

From

€10857EUR$10,995USD£9,066GBP

The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups

 Report
July 2022
60 Pages
France

€9916EUR$10,393USD£8,000GBP

Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

 Report
December 2018
180 Pages
Global

From

€961EUR$973USD£802GBP

€1373EUR$1,390USD£1,146GBP

Belgium Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)

 Report
July 2022
85 Pages
Belgium

From

€4690EUR$4,750USD£3,917GBP

Organ Transplantation Immunosuppressive Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Product Type

 Report
August 2022
102 Pages
Global

From

€3500EUR$3,797USD£3,025GBP

2024 Succeeding in the Pharmaceutical Market: Supplier Strategies and Capabilities

 Report
January 2024
Global

From

€3456EUR$3,500USD£2,886GBP

Communicable Diseases Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
96 Pages
Global

From

€3500EUR$3,797USD£3,025GBP

Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
643 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Entecavir Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
84 Pages
Global

From

€3500EUR$3,797USD£3,025GBP

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups

 Report
June 2022
91 Pages
Global

€9916EUR$10,393USD£8,000GBP

Immunomodulators - Global Strategic Business Report

 Report
November 2024
94 Pages
Global

From

€5530EUR$5,600USD£4,618GBP

Mouth Ulcers Treatment - Global Strategic Business Report

 Report
November 2024
193 Pages
Global

From

€5382EUR$5,450USD£4,494GBP

Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast -2032

 Report
January 2022
200 Pages
Global

From

€5184EUR$5,250USD£4,329GBP

€7406EUR$7,500USD£6,184GBP

2,461 Results (Page 47 of 124)
- 1
- 45
- 46
- 47
- 48
- 49

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.